NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Caidya

Caidya

Private
Raleigh, North CarolinaHealthcare & Life Scienceshttps://www.caidya.com/

Last Round

Private Equity

Jan 13, 2025

Total Funding Raised

$440.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Caidya is a global, full-service contract research organization (CRO) that provides clinical development services, including regulatory strategy, clinical operations, and data management, to support biopharmaceutical innovators.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROclinical trial managementclinical research servicesdrug developmentpharmacovigilancebiometricsregulatory affairsearly-phase clinical developmentclinical trial executionbiotech outsourcingmulti-regional clinical trialsdrug safety monitoringclinical trial consultingpharma outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Caidya Comparables

Compare Caidya with similar companies based on industry and business-model similarity.

Caidya comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Worldwide Clinical Trials
88%
Novotech Health Holdings
88%
Allucent
87%

Caidya Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJan 13, 2025
Series C ExtensionJul 7, 2021
Series CDec 17, 2020
Series BOct 16, 2019
Series AAug 14, 2018
Seed
Nov 30, 2016

Key People

Founding team and executive leadership

Barbara Lopez Kunz

Chief Executive Officer

Executive Team

George Baeder

Advisor To Chief Executive Officer

Executive Team

Michael Clay

Chief Operating Officer

Executive Team

Caidya Investors

Notable investors and investment history

Caidya investors
InvestorRounds
SpringHill ManagementSeries C Extension
Morgan Stanley Expansion CapitalPrivate Equity, Series C
Hatteras Venture PartnersPrivate Equity, Series C, Series B
Fidelity Management & Research CompanySeries C
Legend CapitalSeries B
Harbert Growth PartnersPrivate Equity
HongShanSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 17, 2026

    Michael Clay appointed as the new COO.

  • Oct 10, 2025

    Pfizer appears to be a new customer, per job posting.

Caidya Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Caidya Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Caidya's valuation, stock price, and market status.

Firmographic Details

HeadquartersRaleigh, North Carolina
Employee Range748
Year Founded2021
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.